SEOM-GEIS clinical guideline for gastrointestinal stromal tumors (2022)

Otros/as autores/as

Institut Català de la Salut

[Serrano C] Sarcoma Translational Research Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Álvarez R] Hospital General Universitario Gregorio Marañón, Madrid, Spain. [Carrasco JA] Hospital Álvaro Cunqueiro–Complejo Hospitalario Universitario de Vigo, Pontevedra, Spain. [Marquina G] Hospital Universitario Clínico San Carlos, Madrid, Spain. [Martínez-García J] Hospital Universitario Virgen de la Arrixaca, Murcia, Spain. [Martínez-Marín V] Hospital Universitario la Paz, Madrid, Spain

Vall d'Hebron Barcelona Hospital Campus

Fecha de publicación

2023-09-05T12:07:25Z

2023-09-05T12:07:25Z

2023-09

Resumen

Avapritinib; Imatinib; Ripretinib


Avapritinib; Imatinib; Ripretinib


Avapritinib; Imatinib; Ripretinib


Gastrointestinal stromal tumor (GIST) is the most common malignant neoplasm of mesenchymal origin, and a paradigmatic model for a successful rational development of targeted therapies in cancer. The introduction of tyrosine kinase inhibitors with activity against KIT/PDGFRA in both localized and advanced stages has remarkably improved the survival in a disease formerly deemed resistant to all systemic therapies. These guidelines are elaborated by the conjoint effort of the Spanish Society of Medical Oncology (SEOM) and the Spanish Sarcoma Research Group (GEIS) and provide a multidisciplinary and updated consensus for the diagnosis and treatment of GIST patients. We strongly encourage that the managing of these patients should be performed within multidisciplinary teams in reference centers.

Tipo de documento

Artículo


Versión publicada

Lengua

Inglés

Publicado por

Springer

Documentos relacionados

Clinical and Translational Oncology;25

https://doi.org/10.1007/s12094-023-03177-7

Citación recomendada

Esta citación se ha generado automáticamente.

Derechos

Attribution 4.0 International

http://creativecommons.org/licenses/by/4.0/

Este ítem aparece en la(s) siguiente(s) colección(ones)